← all signals · sectors · research
Arcus Biosciences, Inc. RCUS
SIC 2834 — Pharmaceutical Preparations · CIK 1724521
This page lists every Interactive Market Data signal that fired on this company across fiscal years, with the calibrated net-of-cost forward-return prediction. Predictions use a triple → pair → singles fallback against our backtest panel (~32K (cik × fy) signal combos, net of execution costs at 5 bps half-spread + ADV-tiered borrow).
FY2023 short
2 signals fired ·
match: pair
capex_spike, fcf_turn_negative
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +2.92% |
| 60 days | +1.26% |
| 252 days (1y) | -2.11% |
FY2022 long
2 signals fired ·
match: pair
fcf_turn_positive, profit_to_loss
| Horizon | Predicted net PnL |
|---|---|
| 20 days | -0.28% |
| 60 days | +4.07% |
| 252 days (1y) | +21.68% |
FY2021 short
4 signals fired ·
match: triple
accruals_quality_low, capex_spike, fcf_ni_divergence, fcf_turn_negative
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +5.17% |
| 60 days | +4.85% |
| 252 days (1y) | — |
FY2021 long
4 signals fired ·
match: triple
accruals_quality_low, capex_spike, fcf_ni_divergence, fcf_turn_negative
| Horizon | Predicted net PnL |
|---|---|
| 20 days | — |
| 60 days | — |
| 252 days (1y) | +27.16% |
FY2020 long
1 signal fired ·
match: singles_avg
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +1.81% |
| 60 days | +4.48% |
| 252 days (1y) | +19.70% |
Methodology: /methodology · Live JSON: /api/company/1724521/financials